Top domestic and imported automakers Hyundai Motor and Mercedes-Benz may give way to other competitors in sales performance in South Korea this year.
According to industry tracker CarIsYou Data Research Center, Kia Corp. registered 37,371 new vehicles last month, surpassing Hyundai's 35,993 units, including those from the Genesis brand, to become the top domestic carmaker for the first time.
While Kia trails Hyundai in terms of total registered vehicles between January and August, its strong performance, including the Sorento SUV topping sales charts last month, is still noteworthy in the auto industry.
Last month, BMW registered 7,305 units in the imported vehicle market, surpassing Mercedes-Benz's 5,943 units to top the sales charts.
As of last month, Mercedes-Benz had 50,627 registered vehicles and BMW had 50,349 registered vehicles, indicating that the sales gap between the two automakers is narrowing.


Australia’s December Trade Surplus Expands but Falls Short of Expectations
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Asian Markets Slip as AI Spending Fears Shake Tech, Wall Street Futures Rebound
U.S. Stock Futures Edge Higher as Tech Rout Deepens on AI Concerns and Earnings
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Thailand Inflation Remains Negative for 10th Straight Month in January
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 



